Basic Information
RNALocate ID: | RLID:01002256 |
RNA Symbol: | hsa-miR-196b-5p |
Localization: | Nucleolus |
RNA Information
RNA Name: | hsa-miR-196b |
RNA ID: | miRBase:MIMAT0001080 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23940654 |
Tissue/Cell Line: | HeLa cells |
Method: | qRT-PCR |
Detection of mature miRNAs in the HeLa nucleolus. The abundance ratios of the detected miRNAs in nucleolus vs. whole cells are plotted against their abundance in the nucleolus. The box encompasses the miRNAs with high nucleolar abundance (Ct smaller than 30) and nucleolar/cell ratio that exceeds 0.3. Originally published in PLoS One. Li ZF, et al, 2013. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002254 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002255 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11002709 | Exosome | Brain tissue | 23382797 |
RLID:11002710 | Exosome | Plasma | 23663360 |
RLID:11002711 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11002712 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11002713 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000446 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine | |
RLID-D:11001222 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-196b-5p | Peripheral arterial disease | MNDR-E-MI-24129 |
MNDR | hsa-miR-196b-5p | Oral squamous cell carcinoma | MNDR-E-MI-24130 |
MNDR | hsa-miR-196b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-24131 |
MNDR | hsa-miR-196b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-24132 |
MNDR | hsa-miR-196b-5p | Lymphoma | MNDR-E-MI-24133 |
MNDR | hsa-miR-196b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-24134 |
MNDR | hsa-miR-196b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-24135 |
MNDR | hsa-miR-196b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-24136 |
MNDR | hsa-miR-196b-5p | Breast cancer luminal | MNDR-E-MI-24137 |
MNDR | hsa-miR-196b-5p | Niemann-pick disease type c | MNDR-E-MI-24138 |
MNDR | hsa-miR-196b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-24139 |
MNDR | hsa-miR-196b-5p | Dermatomyositis | MNDR-E-MI-24140 |
MNDR | hsa-miR-196b-5p | Prostate cancer | MNDR-E-MI-24141 |
MNDR | hsa-miR-196b-5p | Gastric cancer | MNDR-E-MI-24142 |
MNDR | hsa-miR-196b-5p | Esophageal carcinoma | MNDR-E-MI-24143 |
MNDR | hsa-miR-196b-5p | Seizures | MNDR-E-MI-24144 |
MNDR | hsa-miR-196b-5p | Mixed lineage leukaemia (mll)-rearranged leukaemia | MNDR-E-MI-24145 |
MNDR | hsa-miR-196b-5p | Acute leukemia | MNDR-E-MI-24146 |
MNDR | hsa-miR-196b-5p | Huntington disease | MNDR-E-MI-24147 |
MNDR | hsa-miR-196b-5p | Chorea | MNDR-E-MI-24148 |
MNDR | hsa-miR-196b-5p | Uterine fibroid | MNDR-E-MI-24149 |
MNDR | hsa-miR-196b-5p | Lung cancer | MNDR-E-MI-24150 |
MNDR | hsa-miR-196b-5p | Down syndrome | MNDR-E-MI-24151 |
MNDR | hsa-miR-196b-5p | Parkinson disease | MNDR-E-MI-24152 |
MNDR | hsa-miR-196b-5p | Niemann-pick disease | MNDR-E-MI-24153 |
MNDR | hsa-miR-196b-5p | Breast cancer | MNDR-E-MI-24154 |
MNDR | hsa-miR-196b-5p | Pancreatic cancer | MNDR-E-MI-24155 |
MNDR | hsa-miR-196b-5p | HCV | MNDR-E-MI-24156 |
MNDR | hsa-miR-196b-5p | Rectum adenocarcinoma | MNDR-E-MI-24157 |
MNDR | hsa-miR-196b-5p | Nephroblastoma | MNDR-E-MI-24158 |
MNDR | hsa-miR-196b-5p | Colon adenocarcinoma | MNDR-E-MI-24159 |
MNDR | hsa-miR-196b-5p | Prostate adenocarcinoma | MNDR-E-MI-24160 |
MNDR | hsa-miR-196b-5p | Carcinoma ductal breast | MNDR-E-MI-24161 |
MNDR | hsa-miR-196b-5p | Glioblastoma | MNDR-E-MI-24162 |
MNDR | hsa-miR-196b-5p | Glioma | MNDR-E-MI-24163 |
MNDR | hsa-miR-196b-5p | Osteosarcoma | MNDR-E-MI-24164 |
MNDR | hsa-miR-196b-5p | Inclusion body myositis | MNDR-E-MI-24165 |
MNDR | hsa-miR-196b-5p | Breast carcinoma | MNDR-E-MI-24166 |
MNDR | hsa-miR-196b-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-24167 |
MNDR | hsa-miR-196b-5p | Gastric adenocarcinoma | MNDR-E-MI-24168 |
MNDR | hsa-miR-196b-5p | Lung squamous cell carcinoma | MNDR-E-MI-24169 |
MNDR | hsa-miR-196b-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-24170 |
MNDR | hsa-miR-196b-5p | Lung adenocarcinoma | MNDR-E-MI-24171 |
MNDR | hsa-miR-196b-5p | Adrenocortical carcinoma | MNDR-E-MI-24172 |
MNDR | hsa-miR-196b-5p | Thyroid carcinoma | MNDR-E-MI-24173 |
MNDR | hsa-miR-196b-5p | Papillary thyroid carcinoma | MNDR-E-MI-24174 |
MNDR | hsa-miR-196b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-24175 |
MNDR | hsa-miR-196b-5p | Brain stem cancer | MNDR-E-MI-24176 |
MNDR | hsa-miR-196b-5p | Carcinoma renal cell | MNDR-E-MI-24177 |
MNDR | hsa-miR-196b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-24178 |
MNDR | hsa-miR-196b-5p | Renal clear cell carcinoma | MNDR-E-MI-24179 |
MNDR | hsa-miR-196b-5p | Cholangiocarcinoma | MNDR-E-MI-24180 |
MNDR | hsa-miR-196b-5p | Esophageal cancer | MNDR-E-MI-24181 |
MNDR | hsa-miR-196b-5p | Lung small cell carcinoma | MNDR-E-MI-24182 |
MNDR | hsa-miR-196b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-24183 |
MNDR | hsa-miR-196b-5p | Testicular germ cell cancer | MNDR-E-MI-24184 |
MNDR | hsa-miR-196b-5p | Breast invasive carcinoma | MNDR-E-MI-24185 |
MNDR | hsa-miR-196b-5p | Hepatocellular carcinoma | MNDR-E-MI-24186 |
MNDR | hsa-miR-196b-5p | Embryonal cancer | MNDR-E-MI-24187 |
MNDR | hsa-miR-196b-5p | B-cell lymphoma | MNDR-E-MI-24188 |
MNDR | hsa-miR-196b-5p | Rheumatoid arthritis | MNDR-E-MI-24189 |
MNDR | hsa-miR-196b-5p | Retinoblastoma | MNDR-E-MI-24190 |
MNDR | hsa-miR-196b-5p | Abdominal aortic aneurysm | MNDR-E-MI-24191 |
MNDR | hsa-miR-196b-5p | Hodgkin lymphoma | MNDR-E-MI-24192 |
MNDR | hsa-miR-196b-5p | Tonsil cancer | MNDR-E-MI-24193 |
MNDR | hsa-miR-196b-5p | Acute myelocytic leukemia | MNDR-E-MI-24194 |
MNDR | hsa-miR-196b-5p | Colorectal cancer | MNDR-E-MI-24195 |
MNDR | hsa-miR-196b-5p | Nasopharynx carcinoma | MNDR-E-MI-24196 |
MNDR | hsa-miR-196b-5p | Multiple myeloma | MNDR-E-MI-24197 |
MNDR | hsa-miR-196b-5p | Hypoxia | MNDR-E-MI-24198 |
MNDR | hsa-miR-196b-5p | Uterine cervical neoplasms | MNDR-E-MI-24199 |
MNDR | hsa-miR-196b-5p | Nasopharyngeal cancer | MNDR-E-MI-24200 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BACH1 | Homo sapiens | RR00209417 |
TOP